Akero Therapeutics, Inc. Marketable Securities (Non-Current)
Akero Therapeutics, Inc. had Marketable Securities (Non-Current) of $250.49 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2025-11-07
- 2025-09-30: Marketable Securities, Noncurrent $250.49M.
- 2025-06-30: Marketable Securities, Noncurrent $343.93M.
- 2025-03-31: Marketable Securities, Noncurrent $442.00M.
- 2024-12-31: Marketable Securities, Noncurrent $54.75M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2025-09-30 | $250.49M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $343.93M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $442.00M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $54.75M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $69.82M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $88.13M 10-Q · filed 2024-08-09 |
| 2023-12-31 | $19.28M 10-K · filed 2025-02-28 |
| 2023-09-30 | $58.26M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $19.45M 10-Q · filed 2023-08-11 |